Xuemei Jia (X Jia)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Endometrial Cancer

Dna Damage Response

Long Noncoding Rna

Top Venues

Cell death & disease

Medicina (Kaunas, Lithuania)

Cancer management and research

Archives of gynecology and obstetrics

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Cong, Xin Cui, Yaqian Shi, Xinxing Pan, Ke Huang, Zhe Geng, Pengfei Xu, Lili Ge, Jin Zhu, Juan Xu, Xuemei Jia
Tripartite-motif 3 represses ovarian cancer progression by downregulating lactate dehydrogenase A and inhibiting AKT signaling. Molecular and cellular biochemistry (2024)
Rong Li, Juan Xu, Ming Wu, Shuna Liu, Xin Fu, Wenwen Shang, Ting Wang, Xuemei Jia, Fang Wang
Circulating CD4 + Treg, CD8 + Treg, and CD3 + γδ T Cell Subpopulations in Ovarian Cancer. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Yaqian Shi, Xueyou Xiong, Yu Sun, Zhe Geng, Chaoqun Ma, Xin Cui, Juan Lv, Lili Ge, Xuemei Jia, Juan Xu
IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m 6 A-dependent manner. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (10) (2023)
PengFei Xu, Sujuan Xu, Haiyue Pan, Chencheng Dai, Yiran Xu, Luyao Wang, Yu Cong, Huilin Zhang, Jian Cao, Lili Ge, Xuemei Jia
Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy. Cell death & disease 14 (2) (2023)
Rong Li, Juan Xu, Ming Wu, Shuna Liu, Xin Fu, Wenwen Shang, Ting Wang, Xuemei Jia, Fang Wang
Circulating CD4 + Treg, CD8 + Treg, and CD3 + γδ T Cell Subpopulations in Ovarian Cancer. Medicina (Kaunas, Lithuania) 59 (2) (2023)
PengFei Xu, Sujuan Xu, Haiyue Pan, Chencheng Dai, Yiran Xu, Luyao Wang, Yu Cong, Huilin Zhang, Jian Cao, Lili Ge, Xuemei Jia
Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy. Cell death & disease 14 (2) (2023)
PengFei Xu, Sujuan Xu, Haiyue Pan, Chencheng Dai, Yiran Xu, Luyao Wang, Yu Cong, Huilin Zhang, Jian Cao, Lili Ge, Xuemei Jia
Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy. Cell death & disease 14 (2) (2023)
Rong Li, Juan Xu, Ming Wu, Shuna Liu, Xin Fu, Wenwen Shang, Ting Wang, Xuemei Jia, Fang Wang
Circulating CD4 + Treg, CD8 + Treg, and CD3 + γδ T Cell Subpopulations in Ovarian Cancer. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Qin Yan, Jing Zhou, Ziyu Wang, Xiangya Ding, Xinyue Ma, Wan Li, Xuemei Jia, Shou-Jiang Gao, Jing Zhou
NAT10-dependent N 4 -acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation. Nature communications 14 (1) (2023)
Rui Peng, Shuai Liu, Wenhua You, Yedi Huang, Chupeng Hu, Ye Gao, Xuemei Jia, Gang Li, Ze-Kuan Xu, Yun Chen
Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer. Cancer immunology research 10 (10) (2022)
Lili Ge, Yu Sun, Yaqian Shi, Guangquan Liu, Fang Teng, Zhe Geng, Chaoqun Ma, Hanzi Xu, Juan Xu, Xuemei Jia
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer. Journal of ovarian research 15 (1) (2022)
Zhe Geng, Xinxing Pan, Juan Xu, Xuemei Jia
Friend and foe: the regulation network of ascites components in ovarian cancer progression. Journal of cell communication and signaling (2022)
Xinxing Pan, Zhe Geng, Jingyun Li, Xingxing Li, Mi Zhang, Xusu Wang, Yu Cong, Ke Huang, Juan Xu, Xuemei Jia
Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling. Molecular cancer therapeutics 21 (7) (2022)
Shuihong Yao, Xuemei Jia, Fei Wang, Liuxue Sheng, Pengxia Song, Yanhui Cao, Hongjuan Shi, Weifei Fan, Xiangya Ding, Shou-Jiang Gao, Jing Zhou
CircRNA ARFGEF1 functions as a ceRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3. PLoS pathogens 17 (2) (2021)
Y Shi, Xuemei Jia, J Xu
The new function of circRNA: translation. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (12) (2020)
Yu Sun, Juan Xu, Xuemei Jia
The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives. Cancer management and research 12 (2020)
Lili Ge, Guangquan Liu, Kai Hu, Ke Huang, Mi Zhang, Juan Zhou, Fang Teng, Jian Cao, Chencheng Dai, Xuemei Jia
A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge. Technology in cancer research & treatment 19 (2020)
Chencheng Dai, PengFei Xu, Siyu Liu, Sujuan Xu, Juan Xu, Ziyi Fu, Jian Cao, Mingming Lv, Juan Zhou, Guangquan Liu, Huilin Zhang, Xuemei Jia
Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells. Archives of gynecology and obstetrics 303 (5) (2020)
Juan Xu, Jiacong Wu, Chenyang Fu, Fang Teng, Siyu Liu, Chencheng Dai, Rong Shen, Xuemei Jia
Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells. Journal of cellular physiology 233 (6) (2018)
Guangquan Liu, Pengfei Xu, Ziyi Fu, Xiangdong Hua, Xiaoguang Liu, Wenqu Li, Mi Zhang, Jiacong Wu, Juan Wen, Juan Xu, Xuemei Jia
Prognostic and Clinicopathological Significance of ARID1A in Endometrium-Related Gynecological Cancers: A Meta-Analysis. Journal of cellular biochemistry 118 (12) (2017)